Ditchcarbon
  • Customers
  1. Organizations
  2. Inter Pharma
Public Profile
Pharmaceutical Preparation Manufacturing
TH
updated a month ago

Inter Pharma

Company website

Inter Pharma Co., Ltd., commonly referred to as Inter Pharma, is a leading player in the pharmaceutical industry, headquartered in Thailand (TH). Established in 1993, the company has made significant strides in the development and distribution of high-quality pharmaceutical products across Southeast Asia. Specialising in a diverse range of therapeutic areas, Inter Pharma focuses on innovative solutions that cater to both chronic and acute health conditions. Their core offerings include prescription medications, over-the-counter products, and nutraceuticals, all distinguished by rigorous quality standards and a commitment to research and development. With a strong market presence, Inter Pharma has achieved notable milestones, including partnerships with international organisations and a robust distribution network. This positions the company as a trusted name in the healthcare sector, dedicated to improving patient outcomes through effective and accessible treatments.

DitchCarbon Score

How does Inter Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

27

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Inter Pharma's score of 27 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.

52%

Let us know if this data was useful to you

Inter Pharma's reported carbon emissions

In 2022, Inter Pharma Public Company Limited reported total carbon emissions of approximately 3,251,000 kg CO2e. This figure includes 567,880 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 2,630,270 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity, steam, heating, and cooling. Additionally, the company recorded Scope 3 emissions of about 53,120 kg CO2e, which encompass all other indirect emissions that occur in the value chain. Inter Pharma has not disclosed any specific reduction targets or initiatives as part of its climate commitments. The absence of documented reduction strategies suggests that the company may be in the early stages of developing a comprehensive climate action plan. As of now, there are no emissions data cascaded from a parent or related organization, indicating that the reported figures are solely from Inter Pharma itself. Overall, while Inter Pharma's emissions data provides a snapshot of its carbon footprint, the lack of defined reduction targets highlights an opportunity for the company to enhance its climate commitments and align with industry standards for sustainability.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2022
Scope 1
567,880
Scope 2
2,630,270
Scope 3
53,120

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Inter Pharma's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Inter Pharma is in TH, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Inter Pharma is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Vet Products And Consultant Co., Ltd.

TH
Updated 1 day ago

Sanofi

FR
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Eli Lilly and Company

GB
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Abbvie

US
•
Pharmaceutical Preparation Manufacturing
Updated about 12 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250827.1
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy